University of Cambridge > Talks.cam > Lectures in Cancer Biology and Medicine > The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of concept

  Browse A-Z

Log in

Cambridge users (raven)details Other usersdetails No account?details

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of concept

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Justin Holt.

Abstract not available

This talk is part of the Lectures in Cancer Biology and Medicine series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Homerton Changemakers Centenary Year of the Medical Research Council and International Year of Statistics Vascular Biology Research Seminars

Other talks

Holes in higher Teichmuller theory Cancer stem cells, evolution and heterogeneity Statistics Clinic Summer 2022 II Statistics Clinic Lent 2022 V The launch of the online NatHistFest Sustainable Cities
 

© 2006-2022 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity